Chapa AG, Garza SB, Garza EM, Martínez SG

Language: Spanish
References: 21
Page: 38-46
PDF size: 121.45 Kb.

ABSTRACT

Hyposalivation is a condition frequently encountered in daily practice. Studies show that dry mouth is more common in women and in adults who reported taking a large number of daily medications, particularly those that are suitable for solving problems bone digestive and anxiety. Other causes include high doses of radiation and autoimmune diseases come is Sjögren’s syndrome. Treatment modalities of hyposalivation can range from the use saliva substitutes, restriction and prevention strategies as well as stimulation of secretory capacity available. In this context, the neuroelectrostimulation of the salivary glands is the leading case of effective methods in treating the disease, especially on patients who for some reason require long-term therapy; in these cases, neurostimulation therapy for salivation may be an essential tool.

REFERENCES

1. Chen A, Wai Y, Lee L, Lake S, Woo S. Using the modified Schirmer test to measure mouth dryness: A preliminary study. J Am Dent Assoc 2005; 136: 164-170.

2. Watanabe S, Dawes C. A comparison of the effects of tasting and chewing foods on the flow rate of whole saliva in man. Archives of Oral Biology 1988; 33: 761-764.

3. Dawes C. Salivary flow patterns and the health of hard and soft oral tissues. J Am Dent Assoc 2008; 139: 18S-24S.

4. Cassolato SF, Turnbull RS. Xerostomia: Clinical aspects and treatment. Gerodontology 2003; 20: 64-77.

5. Grisius M. Salivary gland dysfunction: A review of systematic therapies. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 92: 156-162.

6. Fox PC. Differentiation of dry mouth aetiology. Adv Den Res 1996; 10: 13-16.

7. Eveson JW. Xerostomia. Periodontolgy 2000 2008; 48: 85-91.

8. Lafaurie G, Fedele S, Martín GR, Wolff A, Strietzel F, Porter S, Konttinen Y. Biotechnological advances in neuroelectrostimulation for the treatment of hyposalivation and xerostomia. Med Oral Pathol Oral Cir Oral 2009; 14: E76-80.

9. Locker D. Xerostomia in older adults: a longitudinal study. Gerodontology 1995; 12: 18-25.

10. Navazesh M. How can oral health care providers determine if patients have dry mouth? JADA 2003; 134: 613-618.

11. Cassolato SF, Turnbull S. Xerostomia: Clinical aspects and treatment. Gerodontology 2003; 20: 64-77.

12. Mathews SA, Kurien BT, Scofield RH. Oral manifestations of Sjögren’s syndrome. J Dent Res 2008; 87; 308-318.

13. Lynge AM, Smidt D, Nauntote B, Jerlang C, Bjornsson J. Burning mouth syndrome: Etiopathogenic mechanism, symptomatology, diagnosis and therapeutic approaches. Oral Biosci Med 2004; 1: 3-19.

14. Fox P, Brennan M, Pillemer S, Radfar L, Yamano S, Baum B. Sjögren’s syndrome: A model for dental care in the 21st century. JADA 1998; 129: 719-728.

15. Navazesh M, Christensen, Brightman V. Clinical criteria for the diagnosis of salivary gland hypofunction. J Dent Res 1992; 71: 1363-1369.

16. Eveson JW. Xerostomia. Periodontolgy 2000 2008; 48: 85-91.

17. Sreebny LM, Banoczy J, Baum BJ. Saliva: Its role in health and disease. Working Group 10 of the Commission on Oral Health, Research and Epidemiology. Int Dent J 1992; 42 (6): 291-304.

18. Proctor G, Carpenter G. Regulation of salivary gland function by autonomic nerves. Autonomic Neuroscience: Basic and Clinical 2007; 133: 3-18.

19. Hargitai I, Sherman R, Strother J. The effects of electrostimulation on parotid saliva flow. Oral Sur Oral Med Oral Pathol Oral Radiol Endod 2005; 99: 316-320.

20. Strietzel FP, Martín GR, Fedele S, Russo Lo, Mignogna M, Reichart PA, Wolff A. Electrostimulating device in the management of xerostomia. Oral Diseases 2007; 13 (2): 206-213.

21. Ami S, Wolff A. Implant supported electroestimulating device to treat xerostomia: A preliminary study. Clin Implant Dent Relat Res 2010; 12: 62-71.